Tavneos (Avacopan)

Tavneos (Avacopan)

Tavneos

Avacopan

Capsules: 10 mg

ChemoCentryx, Inc

Medical Use

Tavneos, a complement 5a receptor (C5aR) antagonist, is used alongside standard treatments, including glucocorticoids, to help manage severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis in adults. It is important to note that Tavneos does not replace the use of glucocorticoids.

Recommended Dosage: The advised dosage for Tavneos is 30 mg, which equates to three 10 mg capsules, taken twice daily with food. The capsules should not be crushed, chewed, or opened. If a dose is missed, patients should take the next dose at the regular scheduled time and avoid doubling up on doses.